Physician profile
Emily E Cannon
NPI 1053572313
$2,545.71
in general payments reported to CMS, 2019-2025
23 companies · $198 in 2025
The $198 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $614 · 2020: $401 · 2021: $301 · 2022: $642 · 2023: $228 · 2024: $162 · 2025: $198.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $588.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $587.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $846.66 | 2019-2025 | Puraply, Puraply Wound Matrix |
| Intuitive Surgical, INC. | $691.59 | 2019-2025 | Da Vinci Surgical System |
| Baxter Healthcare | $231.52 | 2020-2022 | |
| Genentech USA, INC. | $134.62 | 2019 | |
| Allergan, INC. | $120.39 | 2019 | |
| Myriad Genetic Laboratories, INC. | $86.20 | 2022-2024 | Bracanalysis Cdx, Myrisk |
| Integra Lifesciences Corporation | $79.76 | 2020-2024 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Davol INC. | $44.69 | 2022 | |
| Kerecis Limited | $42.14 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Tela Bio, INC. | $36.93 | 2020-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Janssen Pharmaceuticals, INC | $34.44 | 2021 | |
| Ossur Americas, INC. | $25.70 | 2025 | |
| Hologic Sales and Service, LLC | $24.45 | 2025 | Localizer, Trunode, Trident Specimen Radiography System |
| Ethicon US, LLC | $21.15 | 2020 | |
| Solventum Corporation | $17.98 | 2024 | Activ.A.C. |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $16.12 | 2020 | |
| Standard Bariatrics, INC. | $14.35 | 2022 | |
| W. L. Gore & Associates, INC. | $14.11 | 2019 | |
| Guard Medical INC. | $13.92 | 2023 | Npseal Medium, Npseal Large, Npseal (5) |
| Portola Pharmaceuticals, LLC | $13.68 | 2019 | |
| Tei Biosciences INC | $12.63 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.92 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $10.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Emily Cannon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.